Plus Therapeutics Inc (NASDAQ:PSTV) concluded the trading at $0.84 on current market day with a fall of -14.32% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $0.98 and 5Y monthly beta was reading 0.673 with its price kept floating in the range of $0.83 and $0.9699 on the day. Considering stock’s 52-week price range provides that PSTV hit a high price of $2.67 and saw its price falling to a low level of $0.24 during that period. Over a period of past 1-month, stock came subtracting -41.07% in its value.
With its current market valuation of $14.33 million, Plus Therapeutics Inc is set to declare its quarterly results on 2025-Mar-26. Analysts are in estimates of -0.29 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -0.96 for current year with estimates of that growing to -0.88 in next year.
Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of 1.11M. The average estimate is representing a decrease of -33.66% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of 4.86M in current fiscal year, which will be -16.51% less from revenue generated by the company last year.
In contrast, when we review PSTV stock’s current outlook then short term indicators are assigning it an average of 100% Sell, while medium term indicators are categorizing the stock at an average of 100% Sell. Long term indicators are suggesting an average of 100% Sell for it.
Digging deeper we become aware of the PEG ratio of the PSTV stock which is currently positioned at 0. It further provides that stock’s current price level is -0.77% away from its 20-day simple moving average and is -11.52% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 49.20 while volatility remained at 25.95% over the past week which changes to 19.05% when measuring it over the past month. Beta is valued at 0.80, while measure of average true range or ATR is currently at 0.21.
Having a second look at Plus Therapeutics Inc (NASDAQ:PSTV) provides that stock’s average daily trading volume for 3 months was 16.79 million, while it jumped to 5854940 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 17.00 million.
The percentage of outstanding shares held by the insiders is 2.55% while it is 11.11% for the institutional holders. The figures also indicate that as of 2025-03-31, number of stock’s short shares was 1.25 million which implies a short ratio of 0.03. This shows up a 741.00 of Short Interest in company’s outstanding shares on the day. In March the standing of shares short improved as it was 0.14 million in the previous month. Subtraction of -26.72% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
